Share this post on:

Name :
Anti-BST1 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
Rabbit polyclonal antibody to BST1

Tested applications :
WB, FC

Species reactivity :
Human, Mouse, Rat, Dog, Pig, Cow, Rabbit

Alternative names :
CD157 antibody

Immunogen :

Isotype :
IgG

Preparation :
This antigen of this antibody was klh conjugated synthetic peptide derived from human bst1/cd157 51-150/318

Clonality :
Polyclonal

Formulation :
Liquid, 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Storage instructions :
Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4℃.

Applications :
WB:1:500-2000FC:1μg/Test

Background :
Q10588

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Histone H2B Antibody
Andecaliximab
Ubiquitin Antibody (YA022): Ubiquitin Antibody (YA022) is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to Ubiquitin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Gardos- Channel